Skip to main content
Fig. 1 | Journal of Neuroinflammation

Fig. 1

From: Myeloid-specific TAK1 deletion results in reduced brain monocyte infiltration and improved outcomes after stroke

Fig. 1

Deletion of TAK1 from myeloid cells resulted in reduced infarct and improved functional outcomes at day 3 post stroke. a TAK1ΔM mice had reduced neurological deficit scores (NDS). b Decreased turning bias on the corner test. c Increased locomotor activity. d Decreased infarct area at day 3 post stroke. Data is presented as Mean ± SEM, n = 6–8; *p < 0.05, **p < 0.01 (Two-sample t test or Wilcoxon rank-sum test)

Back to article page